» Articles » PMID: 31606073

RNA Modifications and the Link to Human Disease

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 2019 Oct 14
PMID 31606073
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Ribonucleic acid (RNA) is involved in translation and transcription, which are the mechanisms in which cells express genes (Alberts et al., 2002). The three classes of RNA discussed are transfer RNA (tRNA), messenger RNA (mRNA), and ribosomal RNA (rRNA). mRNA is the transcript encoded from DNA, rRNA is associated with ribosomes, and tRNA is associated with amino acids and is used to read mRNA transcripts to make proteins (Lodish, Berk, Zipursky, et al., 2000). Interestingly, the function of tRNA, rRNA, and mRNA can be significantly altered by chemical modifications at the co-transcriptional and post-transcriptional levels, and there are over 171 of these modifications identified thus far (Boccaletto et al., 2018; Modomics-Modified bases, 2017). Several of these modifications are linked to diseases such as cancer, diabetes, and neurological disorders. In this review, we will introduce a few RNA modifications with biological functions and how dysregulation of these RNA modifications is linked to human disease.

Citing Articles

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.


Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective.

Prodan-Barbulescu C, Ghenciu L, Seclaman E, Bujor G, Enatescu V, Danila A Curr Issues Mol Biol. 2024; 46(10):10846-10853.

PMID: 39451524 PMC: 11506240. DOI: 10.3390/cimb46100644.


Advancements in clinical RNA therapeutics: Present developments and prospective outlooks.

Saw P, Song E Cell Rep Med. 2024; 5(5):101555.

PMID: 38744276 PMC: 11148805. DOI: 10.1016/j.xcrm.2024.101555.


Nanopore Direct RNA Sequencing Data Processing and Analysis Using MasterOfPores.

Cozzuto L, Delgado-Tejedor A, Hermoso Pulido T, Novoa E, Ponomarenko J Methods Mol Biol. 2023; 2624:185-205.

PMID: 36723817 DOI: 10.1007/978-1-0716-2962-8_13.


Comprehensive analysis of key m5C modification-related genes in type 2 diabetes.

Song Y, Jiang Y, Shi L, He C, Zhang W, Xu Z Front Genet. 2022; 13:1015879.

PMID: 36276976 PMC: 9582283. DOI: 10.3389/fgene.2022.1015879.


References
1.
Pallan P, Kreutz C, Bosio S, Micura R, Egli M . Effects of N2,N2-dimethylguanosine on RNA structure and stability: crystal structure of an RNA duplex with tandem m2 2G:A pairs. RNA. 2008; 14(10):2125-35. PMC: 2553729. DOI: 10.1261/rna.1078508. View

2.
Khan M, Rafiq M, Noor A, Hussain S, Flores J, Rupp V . Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability. Am J Hum Genet. 2012; 90(5):856-63. PMC: 3376419. DOI: 10.1016/j.ajhg.2012.03.023. View

3.
Rife J, Cheng C, Moore P, Strobel S . N 2-methylguanosine is iso-energetic with guanosine in RNA duplexes and GNRA tetraloops. Nucleic Acids Res. 1998; 26(16):3640-4. PMC: 147776. DOI: 10.1093/nar/26.16.3640. View

4.
Zhao B, Roundtree I, He C . Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2016; 18(1):31-42. PMC: 5167638. DOI: 10.1038/nrm.2016.132. View

5.
Cardelli M, Marchegiani F, Cavallone L, Olivieri F, Giovagnetti S, Mugianesi E . A polymorphism of the YTHDF2 gene (1p35) located in an Alu-rich genomic domain is associated with human longevity. J Gerontol A Biol Sci Med Sci. 2006; 61(6):547-56. DOI: 10.1093/gerona/61.6.547. View